$Arcturus Therapeutics Ltd.(ARCT)$Lots of negativity surrounding the Arcturus Covid-19 vaccine data. The low neutralizing titers (antibodies) may look disappointing but the response of CD4 and CD8 T cells are very good and could prevent Covid-19 infection. Immunity is more than just antibodies.
T-cells response data for the following vaccines. Biontech/Pfizer: 0.4%, Moderna: 0.2%. Arcturus is a whopping 4 to 8%! You get lesser antibodies with Arcturus but more T-Cells. Antibody immunity is seasonal. T-Cell immunity lasts much longer.
Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.
Comments